ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MERC Mercia Asset Management Plc

33.70
0.20 (0.60%)
Last Updated: 10:11:19
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mercia Asset Management Plc LSE:MERC London Ordinary Share GB00BSL71W47 ORD 0.001P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.60% 33.70 33.00 34.40 33.70 33.50 33.50 597,677 10:11:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 25.88M 2.84M - N/A 0

Mercia Asset Management PLC Mercia announces two new direct investments (1736D)

18/10/2022 7:00am

UK Regulatory


Mercia Asset Management (LSE:MERC)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Mercia Asset Management Charts.

TIDMMERC

RNS Number : 1736D

Mercia Asset Management PLC

18 October 2022

 
 RNS              18 October 2022 
 

Mercia Asset Management PLC

("Mercia", the "Group" or the "Company")

Mercia announces two new direct investments - Axis Spine and Nova Pangaea

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.GBP959million of assets under management, is pleased to announce new direct investments into Axis Spine Technologies Ltd ("Axis Spine") and Nova Pangaea Technologies Ltd ("Nova Pangaea").

Axis Spine

The investment into Axis Spine comes as part of a GBP10.8million funding round. Mercia has made a direct investment of GBP3.0million, alongside GBP3.8million from Mercia's managed funds. MedTex Ventures, a US-based venture capital firm focused on the medical device industry, has invested GBP3.0million with the remaining GBP1.0million coming from other external investors. Mercia's managed funds first invested in Axis Spine in 2017.

Following this investment, Mercia holds a 11.7% fully diluted direct equity stake in Axis Spine, with funds managed by Mercia holding a further 33.6% fully diluted equity stake.

Axis Spine is a Med Tech business delivering spinal implants. Axis has a highly differentiated platform of modular implants, designed to address the increasingly recognised and unmet clinical need of cage subsidence. This technology promises to not only reduce post operative spinal segment collapse, but also improve spinal alignment in patients suffering chronic back pain and spinal deformity.

Insertion of Axis' proprietary modular cages requires much less force than conventional implants, they are slimmer and have a wider footprint, thereby reducing the risk of damage to vertebral segment endplates and thus the loss of alignment that impacts one in three patients.

Nova Pangaea

The investment into Nova Pangaea is part of a GBP5.3million funding round. Mercia has made an initial direct investment of GBP2.3million via a convertible loan, alongside GBP1.0million from Mercia's Northern Powerhouse Investment Fund ("NPIF") and a further GBP2.0million from co-investors.

Nova Pangaea is a Clean Tech business focused on creating biofuels and biochar to address some of the most pressing climate concerns of today. Led by CEO Sarah Ellerby, Nova Pangaea provides a patented process called REFNOVA(R) that converts woody and agricultural residues into high-value sustainable products that are used to manufacture Sustainable Aviation Fuel ("SAF") and a range of biochemicals. The process also produces Biochar, which is crucial for carbon dioxide removal and soil enhancement.

Mark Payton, Chief Executive Officer of Mercia, commented: "These are two businesses we have been excited about for some time, actively supporting them within our managed funds. We are pleased to welcome them onto our balance sheet, where we have significant liquidity to support both in reaching their next stage of maturity. Both embody what we look for in UK regional businesses, combining innovative technology with deep sector specialism to create real-world solutions."

"Axis Spine's patented technology has significant benefits over incumbents and, with FDA clearance now received, the team is well placed to move towards commercialisation in the US. We look forward to supporting the team as they scale a unique product.

"Nova Pangaea is part of the solution within multibillion dollar markets as industries and governments alike look to transition to cleaner energy. This funding round will enable the business to invest in its growth, including the delivery of its first commercial production facility in 2023. We are excited to be supporting the scaling of Nova Pangaea as it accelerates its commercialisation, signs new partnerships and ramps up its production capabilities."

-Ends-

For further information, please contact:

 
   Mercia Asset Management PLC 
    Mark Payton, Chief Executive Officer 
    Martin Glanfield, Chief Financial Officer      +44 (0)330 223 
    www.mercia.co.uk                                         1430 
   Canaccord Genuity Limited (NOMAD and Joint    +44 (0)20 7523 
    Broker)                                       8000 
   Simon Bridges, Emma Gabriel 
 
                                                 +44 (0)20 7496 
   Singer Capital Markets (Joint Broker)          3000 
   Harry Gooden, James Moat 
 
                                                 +44 (0)20 3727 
   FTI Consulting                                 1051 
   Tom Blackwell, Immy Ransom 
   mercia@fticonsulting.com 
 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

The Group has a strong UK footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFLFEDIDLDLIF

(END) Dow Jones Newswires

October 18, 2022 02:00 ET (06:00 GMT)

1 Year Mercia Asset Management Chart

1 Year Mercia Asset Management Chart

1 Month Mercia Asset Management Chart

1 Month Mercia Asset Management Chart

Your Recent History

Delayed Upgrade Clock